Article

I3LUNG: Clinical Validation of a Multimodal AI Tool to Support Immunotherapy Decisions in NSCLC

2026-01-22

Abstract excerpt

Despite a decade of immunotherapy, treatment selection in non-small cell lung cancer (NSCLC) still relies on subgroup analyses and clinical scores. I3LUNG ( NCT05537922 ) is currently the largest international, real-world, multimodal, artificial intelligence (AI)-based trial, enrolling 2365 patients. We integrated real-world clinical data (RWD), computed tomography (CT) images, digital pathology (DP), and genomic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4b5d3e98-6614-5208-bc39-7e3bd477a389
DOI: 10.64898/2026.01.16.25342913

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

I3LUNG: Clinical Validation of a Multimodal AI Tool to Support Immunotherapy Decisions in NSCLCDOI 10.64898/2026.01.16.25342913Read

Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligenceSemantic proximity Read

Immunotherapy Efficacy Prediction in Cancer: An Artificial Intelligence Approach with Unannotated H&E Whole-Slide ImagesSemantic proximity Read

Integration of clinical, pathological, radiological, and transcriptomic data improves the prediction of first-line immunotherapy outcome in metastatic non-small cell lung cancerSemantic proximity Read

Multimodal prediction of tyrosine kinase inhibitors therapy outcomes in advanced EGFR-mutated NSCLC patients.Semantic proximity Read

AI-Driven Computational Models for Lung Cancer Diagnosis: A Systematic Review and Meta-AnalysisSemantic proximity Read

Artificial Intelligence (AI) and Machine Learning (ML) in Diagnosing Cancer: Current TrendsSemantic proximity Read

PanoraOnc: A pan-cancer clinico-genomic AI model for transferable outcome predictionsSemantic proximity Read

DeePaN: A deep patient graph convolutional network integratingclinico-genomic evidence to stratify lung cancers benefiting from immunotherapySemantic proximity Read

AI-Driven Predictive Biomarker Discovery with Contrastive Learning to Improve Clinical Trial OutcomesSemantic proximity Read

Non-invasive decision support for NSCLC treatment using PET/CT radiomics.Semantic proximity Read

Prediction of cancer treatment response from histopathology images through imputed transcriptomicsSemantic proximity Read

AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosisSemantic proximity Read